Icon-linkedin Youtube
Search
Contact us
Log in
Search
Contact us
Log in
Icon-linkedin Icon-x Youtube
Back to Schemes

BRCA and HRR gene variants Competency Module

Product Code: BRCA(VARIANT_INTERPRETATION)-25

Free

Deadline to order: N/A

This scheme is an online competency assessment for the classification of breast cancer (BRCA) and homologous recombination repair (HRR) genes

This scheme is applicable to all individuals who classify the pathogenicity of BRCA (BRCA1 and BRCA2) and other HRR gene (PALB2, ATM, RAD15C and CHEK2) variants.

Registration for the next run will be advertised in Autumn 2024. There are two runs per year (autumn and spring) comprising online competency assessment and access to educational webinars by international experts. Delivered in conjunction with GenQA.

Target/Genes:

Online competency assessment for BRCA and HRR gene variant classification

Technology:

Not applicable

Language:

Not applicable

Sample Type:

Online (virtual) case(s)

Accredited:

No

Register Interest Add to Wishlist

EQA Assessment

The aim of this module is to provide an online competency
assessment for the classification of HRR gene variants related to breast /
ovarian and prostate cancer. This assessment is open to individuals who
classify the pathogenicity of variants and aimed to provide assurance of
competence to accurately achieve this in the most up-to-date manner.

For each ONLINE assessment, participants receive six variants to classify within four weeks.  Participants can choose to classify some or all of the variants.   For each variant classification submitted, participants should also provide the criteria evidence for their classification.  

The classifications and evidence are pre-agreed by an
international panel of experts.

To
register to participate, please use this link HERE.

Sample Details

Online only- no samples provided for this scheme

EQA Results

On completion of the assessment, all participants will receive:

  • An individual report which summarises their classification
  • A summary report to enable benchmarking against the expert predicted classifications
  • A certificate of participation

Participation Information

This assessment delivered in conjunction with GenQA and is sponsored through an unrestricted
educational grant from AstraZeneca and MSD, and there is no fee to participate.

Details of the next available assessment are provided upon registration, along with registration details for educational webinars. 

Relevant resources:

ACMG Variant classification guidelines

Clingen SVI updates

ACGS 2020 Best Practice Guidelines for Variant Classification

CanVIG-UK Guidelines for cancer susceptibility

How it works

Register

  • Enrol before the closing date
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via QA Manager

Review & get certified

  • EMQN benchmarks your data
  • Receive final report & Certificate of Participation

Enquire about this scheme

Contact Information

Phone

+44 161 757 1591

Featured EQA Schemes

  • Genomic and Inherited Disorders

    Charcot-Marie-Tooth disease / Hereditary Neuropathy with liability for Pressure Palsies (CMT/HNPP) (PMP22 and optional gene panel testing for other CMT-associated genes).

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £445.00

    Deadline to order: 30/11/2025

    Applicable to all labs undertaking molecular genetic testing for these disorders.

    • Language: English, German
    • Accredited: Yes
    Buy Scheme More Information

  • Pre-analytical processes

    cfDNA extraction from plasma (Round 2)

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    Free

    Registration closed: 31/03/2025

    Applicable for all labs extracting cfDNA from plasma. Two rounds of EQA per year – purchase each separately.
    This EQA will be distributed in SEPTEMBER 2025.

    • Language: English
    • Accredited: No
    Register Interest More Information

  • Genomic and Inherited Disorders

    Congenital Adrenal Hyperplasia (CAH)

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £445.00

    Registration closed: 30/11/2024

    Applicable to all labs undertaking molecular genetic testing for this disorder.

    • Language: English, German
    • Accredited: Yes
    Register Interest More Information

  • Molecular Pathology

    Colorectal cancer [Tissue]

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £630.00

    Registration closed: 28/02/2025

    Applicable to all labs undertaking molecular testing for this cancer using FFPE tissue.

    • Language: English
    • Accredited: Yes
    Register Interest More Information

  • Pre-analytical processes

    cfDNA extraction from plasma (Round 1)

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    Free

    Registration closed: 28/02/2025

    Applicable for all labs extracting cfDNA from plasma. Two rounds of EQA per year – purchase each separately.
    This EQA will be distributed in MARCH 2025.

    • Language: English
    • Accredited: No
    Register Interest More Information

  • Genomic and Inherited Disorders

    Cardiac Genetics Gene Panel: Hypertrophic Cardiomyopathies

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £445.00

    Registration closed: 30/11/2024

    Applicable to labs that undertake NGS-based testing for this group of disorders (including targeted panel testing/ virtual panel /clinical exome / WES / WGS)

    • Language: English
    • Accredited: Yes
    Register Interest More Information

  • Molecular Pathology

    Breast cancer (ESR1 cfDNA testing) [Plasma]

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £285.00

    Registration closed: 28/02/2025

    Applicable to labs undertaking molecular testing of the ESR1 gene in cfDNA

    • Language: English
    • Accredited: No
    Register Interest More Information

  • Genomic and Inherited Disorders

    Cardiac Genetics Gene Panel: Arrhythmias

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £445.00

    Registration closed: 30/11/2024

    Applicable to labs that undertake NGS-based testing for this group of disorders (including targeted panel testing/ virtual panel /clinical exome / WES / WGS)

    • Language: English, French
    • Accredited: Yes
    Register Interest More Information

  • Molecular Pathology

    Breast cancer (AKT pathway gene testing (PIK3CA, AKT1, PTEN) [Tissue]

    Product Code: BRCA(VARIANT_INTERPRETATION)-25

    From £285.00

    Registration closed: 28/02/2025

    Applicable to labs undertaking molecular testing of the PIK3CA, AKT1 and PTEN genes in this type of cancer.

    • Language: English
    • Accredited: Yes
    Register Interest More Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.

EMQN Office 

Third Floor, ICE Building, 3 Exchange Quay

Salford, M5 3ED

office@emqn.org 
+44 161 757 1591

Subscribe to our newsletter

Subscribe
Contact us for more information
Contact us
Click here for more information

Subscribe to our newsletter

Subscribe
Contact us for more information
Contact us

EMQN Office

Unit 4, Enterprise House
Pencroft Way
Manchester Science Park
Manchester
M15 6SE
UK

office@emqn.org
+44 161 757 1591

Click here for more information

Terms & Conditions | Privacy Policy 

©2025 EMQN. All rights reserved.